Explore

FDA's Medical Device

FDA's Medical Device Software Regulation Strategy 2020

Boston, United States
19 - 20 November 2020
29 days until the conference begins

Important Dates

Abstract Submission Deadline
31st October 2020

About FDA's Medical Device

The growth of the medical software industry outpaces the design of FDA's regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their interoperability was never anticipated. How can you anticipate and defend against the malicious remote hacking and shut down of an insulin infusion pump? Can one software program defeat the performance capability or back up safety features of another software program?

Call for Papers

is seminar will focus on addressing these concerns and educating participants on FDA’s recent medical device software regulation strategies.

Seminar instructor Casper Uldriks is an ex-FDA official who has spent 32 years with the FDA. His engagements focus on advertising and promotion, recalls, corrections and removals and enforcement. He currently trains FDA personnel and counsels clients on wide range of topics, including: FDA inspections; import operations; advertising and promotion; corrective and preventive actions; medical device reporting and corporate reorganization to improve conformance to FDA’s requirements.

Download Brochure

The medical device trade and healthcare professionals remain plagued by other issues, such as the interoperability of devices from different manufacturers, or software validation that is limited to the immediate use of the software rather than its performance with other software programs, and software hacking protection applications. In case of software malfunction, fixing the malfunction or bug can get more difficult as software gets increasingly sophisticated, customized by users and placed in a network system. Under these circumstances, it is difficult to decide who is responsible for managing and fixing software problems.

This seminar will help those involved in overcoming these commercial and regulatory obstacles. It will highlight the need for firms to remain current with technological tools and strategy to remain competitive, and ideally, outside FDA’s regulatory radar. Going further, it will instruct participants on how to apply these tools and strategies to ensure the following factors:

  • Software functionality
  • Risk identification
  • Software protection
  • Problem detection
  • Response strategy
For those who have addresse

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.